首页> 外文OA文献 >NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies
【2h】

NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies

机译:microRNA-146a缺陷小鼠中的NF-κB失调驱动了髓系恶性肿瘤的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MicroRNA miR-146a has been implicated as a negative feedback regulator of NF-κB activation. Knockout of the miR-146a gene in C57BL/6 mice leads to histologically and immunophenotypically defined myeloid sarcomas and some lymphomas. The sarcomas are transplantable to immunologically compromised hosts, showing that they are true malignancies. The animals also exhibit chronic myeloproliferation in their bone marrow. Spleen and marrow cells show increased transcription of NF-κB–regulated genes and tumors have higher nuclear p65. Genetic ablation of NF-κB p50 suppresses the myeloproliferation, showing that dysregulation of NF-κB is responsible for the myeloproliferative disease.
机译:MicroRNA miR-146a被认为是NF-κB激活的负反馈调节剂。在C57BL / 6小鼠中敲除miR-146a基因会导致组织学和免疫表型定义的髓样肉瘤和某些淋巴瘤。肉瘤可移植到免疫受损的宿主上,表明它们是真正的恶性肿瘤。这些动物还在其骨髓中表现出慢性骨髓增殖。脾和骨髓细胞显示出NF-κB调控基因的转录增加,肿瘤的核p65更高。 NF-κBp50的基因切除可抑制骨髓增生,表明NF-κB的失调是造成骨髓增生性疾病的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号